Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors

Journal of Medicinal Chemistry

Volumn 52, Issue 23, 2009, Pages 7372-7375

  Sinha, Bhaswati ^a   Cao, Zhengyu ^b   Murray, Thomas F ^b   Aldrich, Jane V ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; DERMORPHIN DERIVATIVE; ELECTROPHILE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ISOTHIOCYANIC ACID; OPIATE RECEPTOR; TRITIUM;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COVALENT BOND; FEMALE; LIGAND BINDING; NONHUMAN; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

AFFINITY LABELS; AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DISCOVERY; OPIOID PEPTIDES; RECEPTORS, OPIOID, MU;

EID: 72249085984     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9007592     Document Type: Article

References (23)

1. Aldrich, J. V.; Vigil-Cruz, S. C. Narcotic Analgesics. In Burger's Medicinal Chemistry and Drug Discovery, 6th ed.; John Wiley, Inc.: New York, 2003; Vol.6, pp 329-481.
2. Chen, Y.; Mestek, A.; Liu, J.; Hurley, J. A.; Yu, L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 1993, 44, 8-12.
3. Fukuda, K.; Kato, S.; Mori, K.; Nishi, M.; Takeshima, H. Primary structures and expression from cDNAs of rat opioid receptor deltaand mu-subtypes. FEBS Lett. 1993, 327, 311-314. (Pubitemid 23228574)
4. Law, P. Y.; Wong, Y. H.; Loh, H. H. Mutational analysis of the structure and function of opioid receptors. Biopolymers (Pept. Sci.) 1999, 51, 440-455. (Pubitemid 30262487)
5. Takemori, A. E.; Portoghese, P. S. Affinity labels for opioid receptors. Annu. Rev. Pharmacol. Toxicol. 1985, 25, 193-223.
6. Chen, C.; Xue, J. C.; Zhu, J.; Chen, Y. W.; Kunapuli, S.; de Riel, J. K.; Yu, L.; Liu-Chen, L. Y. Characterization of irreversible binding of beta-funaltrexamine to the cloned rat mu opioid receptor. J. Biol. Chem. 1995, 270, 17866-17870.
7. Chen, C.; Yin, J.; de Riel, J. K.; DesJarlais, R. L.; Raveglia, L. F.; Zhu, J.; Liu-Chen, L. Y. Determination of the amino acid residue involved in [3H]beta-funaltrexamine covalent binding in the cloned rat mu-opioid receptor. J. Biol. Chem. 1996, 271, 21422-21429.
8. Zhang, Y.; McCurdy, C. R.; Metzger, T. G.; Portoghese, P. S. Specific cross-linking of Lys233 and Cys235 in the mu opioid receptor by a reporter affinity label. Biochemistry 2005, 44, 2271-2275.
9. Glasel, J. A.; Venn, R. F. The sensitivity of opiate receptors and ligands to short wavelength ultraviolet light. Life Sci. 1981, 29, 221-228.
10. Bowen, W. D.; Hellewell, S. B.; Kelemen, M.; Huey, R.; Stewart, D. Affinity labeling of delta-opiate receptors using [D-Ala2,Leu5, Cys6]enkephalin. Covalent attachment via thiol-disulfide exchange. J. Biol. Chem. 1987, 262, 13434-13439.
11. Szucs, M.; Belcheva, M.; Simon, J.; Benyhe, S.; Toth, G.; Hepp, J.; Wollemann, M.; Medzihradszky, K. Covalent labeling of opioid receptors with 3H-D-Ala2-Leu5-enkephalin chloromethyl ketone. I. Binding characteristics in rat brain membranes. Life Sci. 1987, 41, 177-184.
12. Aldrich, J. V.; Kumar, V.; Dattachowdhury, B.; Peck, A. M.; Wang, X.; Murray, T. F. Solid phase synthesis and application of labeled peptide derivatives: probes of receptor-opioid peptide interactions. Int. J. Pept. Res. Ther. 2008, 14, 315-321.
13. Benyhe, S.; Hepp, J.; Simon, J.; Borsodi, A.; Medzihradszky, K.; Wollemann, M. Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone: a mu specific affinity label for the opioid receptor. Neuropeptides 1987, 9, 225-235.
14. Shimohigashi, Y.; Takada, K.; Sakamoto, H.; Matsumoto, H.; Yasunaga, T.; Kondo, M.; Ohno, M. Discriminative affinity labelling of opioid receptors by enkephalin and morphiceptin analogues containing 3-nitro-2-pyridinesulphenyl- activated thiol residues. J. Chromatogr. 1992, 597, 424-428.
15. Choi, H.; Murray, T. F.; Aldrich, J. V. Synthesis and evaluation of potential affinity labels derived from endomorphin-2. J. Pept. Res. 2003, 61, 58-62.
16. Melchiorri, P.; Negri, L. The dermorphin peptide family. Gen. Pharmacol. 1996, 27, 1099-1107.
17. Chavkin, C.; Goldstein, A. Specific receptor for the opioid peptide dynorphin: structure-activity relationships. Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 6543-6547.
18. Choi, H.; Murray, T. F.; Aldrich, J. V. Dermorphin-based potential affinity labels for mu-opioid receptors. J. Pept. Res. 2003, 61, 40-45.
19. Leelasvatanakij, L.; Aldrich, J. V. A solid-phase synthetic strategy for the preparation of peptide-based affinity labels: synthesis of dynorphin A analogs. J. Pept. Res. 2000, 56, 80-87.
20. Balse-Srinivasan, P.; Grieco, P.; Cai, M.; Trivedi, D.; Hruby, V. J. Structure-activity relationships of novel cyclic alpha-MSH/beta- MSHhybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R. J. Med. Chem. 2003, 46, 3728-3733.
21. Arttamangkul, S.; Ishmael, J. E.; Murray, T. F.; Grandy, D. K.; DeLander, G. E.; Kieffer, B. L.; Aldrich, J. V. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence. J. Med. Chem. 1997, 40, 1211-1218.
22. Maeda, D. Y.; Ishmael, J. E.;Murray, T. F.; Aldrich, J. V. Synthesis and evaluation of N,N-dialkyl enkephalin-based affinity labels for delta opioid receptors. J. Med. Chem. 2000, 43, 3941-3948.
23. Tam, S. W.; Liu-Chen, L. Y. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. J. Pharmacol. Exp. Ther. 1986, 239, 351-357.